Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All zinc studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta-analysis of randomized, double-blind and placebo-controlled trials

Wang et al., The Clinical Respiratory Journal, doi:10.1111/crj.12646
May 2017  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020
 
*, now known with p = 0.0000013 from 44 studies, recognized in 11 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19early.org
Meta analysis of 6 randomized, double-blind, placebo-controlled trials with 2,216 severe pneumonia patients showing that zinc given as an adjunct therapy significantly reduced mortality caused by severe pneumonia.
6 meta analyses show significant improvements with zinc for mortality Abuhelwa, Olczak-Pruc, Rheingold, Tabatabaeizadeh, Xie, severity Fan, and cases Fan.
Currently there are 44 zinc treatment for COVID-19 studies, showing 29% lower mortality [10‑44%], 44% lower ventilation [4‑68%], 26% lower ICU admission [-7‑49%], 20% lower hospitalization [4‑34%], and 22% fewer cases [-10‑45%].
Wang et al., 31 May 2017, peer-reviewed, 2 authors.
This PaperZincAll
Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta‐analysis of randomized, double‐blind and placebo‐controlled trials
Linlin Wang, Yuanlin Song
The Clinical Respiratory Journal, doi:10.1111/crj.12646
Background: Pneumonia is a major cause of morbidity and mortality of children. Zinc is known to play a central role in the immune system. The deficiency of zinc increased susceptibility to infectious diseases. Objective: To investigate the clinical efficacy of zinc given as an adjunct therapy to the treatment of severe pneumonia. Methods: The PubMed, Embase, MEDLINE TM and the Cochrane Central Register of Controlled Trials were searched to identify all randomized, double-blind and placebo-controlled (DBPC) trials which evaluated the clinical efficacy of zinc given as an adjunct in the treatment of severe pneumonia and published between January 1966 and October 2015. Results: Six randomized DBPC trials including 2216 patients with severe pneumonia were eligible. The results suggested that zinc given as an adjunct therapy to the treatment of severe pneumonia had no significant improvement of treatment failure (RR 5 0.97, P 5 .71) and change of antibiotic therapy (RR 5 1.09, P 5 .52). We also found a favorable trend for clinical deterioration of severe pneumonia but with no statistical significance (RR 5 0.88, P 5 .55). Zinc produced a significant reduction in mortality caused by severe pneumonia (RR 5 0.43, P 5 .01). Conclusions: Zinc given as an adjunct to the treatment of severe pneumonia is effective in reducing the mortality of severe pneumonia, and has no significant effects on treatment failure and change of antibiotic therapy.
CONFLICT OF INTEREST The authors had no conflicts of interest to declare in relation to this article. AUTHOR CONTRIBUTIONS Searched the database, judged study eligibility, extracted data and did the meta-analysis and drafted the article: Wang Designed the study and revised this paper: Song All authors have read and approve this version of the article.
References
Bao, Knoell, Zinc modulates airway epithelium susceptibility to death receptor-mediated apoptosis, Am J Physiol Lung Cell Mol Physiol
Bao, Prasad, Beck, Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients, Transl Res
Basnet, Shrestha, Sharma, A randomized controlled trial of zinc as adjuvant therapy for severe pneumonia in young children, Pediatrics
Bhutta, Black, Brown, Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group, J Pediatr
Castillo-Duran, Heresi, Fisberg, Uauy, Controlled trial of zinc supplementation during recovery from malnutrition: effects on growth and immune function, Am J Clin Nutr
Fu, Ding, Zhuang, Zhou, Effects of zinc supplementation on the incidence of mortality in preschool children: a meta-analysis of randomized controlled trials, PLoS One
Higgins, Altman, Sterne, Chapter 8: assessing risk of bias in included studies
Lazzerini, Ronfani, Oral zinc for treating diarrhoea in children, Cochrane Database Syst Rev
Liu, Johnson, Cousens, Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000, Lancet
Raqib, Roy, Rahman, Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis, Am J Clin Nutr
Roth, Richard, Black, Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials, Int J Epidemiol
Semp Ertegui, Estrella, Rodríguez, Zinc as an adjunct to the treatment of severe pneumonia in Ecuadorian children: a randomized controlled trial, Am J Clin Nutr
Shah, Dutta, Shah, Mishra, Role of zinc in severe pneumonia: a randomized double bind placebo controlled study, Ital J Pediatr
Shankar, Prasad, Zinc and immune function: the biological basis of altered resistance to infection, Am J Clin Nutr
Srinivasan, Ndeezi, Mboijana, Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial, BMC Med
Valentiner-Branth, Shrestha, Chandyo, A randomized controlled trial of the effect of zinc as adjuvant therapy in children 2-35 mo of age with severe or nonsevere pneumonia in Bhaktapur, Nepal, Am J Clin Nutr
Wadhwa, Chandran, Aneja, Efficacy of zinc given as an adjunct in the treatment of severe and very severe pneumonia in hospitalized children 2-24 mo of age: a randomized, double-blind, placebo-controlled trial, Am J Clin Nutr
Walker, Ezzati, Black, Global and regional child mortality and burden of disease attributable to zinc deficiency, Eur J Clin Nutr
Yakoob, Theodoratou, Jabeen, Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria, BMC Public Health
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit